Related Experiment Video
Updated: Jul 14, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
[Cardiovascular disease in diabetes mellitus: classical and non-classical risk factors]
Antonela F A Siqueira1, Bianca de Almeida-Pititto, Sandra R G Ferreira
1Departamento de Endocrinologia, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Insights
Diabetes significantly increases cardiovascular disease (CVD) risk and mortality. Effective screening and management of risk factors like hyperglycemia are crucial for prevention in diabetic patients.
Area of Science:
- Endocrinology and Cardiology
- Metabolic Syndrome Research
Context:
- Cardiovascular disease (CVD) is the leading cause of mortality globally, especially in individuals with diabetes.
- Diabetic patients face a 2-4 fold increased risk of cardiovascular events and double the risk of death compared to non-diabetics.
- While CVD mortality has declined, CHD mortality reduction is slower in diabetics.
Purpose:
- To highlight the heightened cardiovascular disease (CVD) risk in diabetic populations.
- To discuss the contributing factors to CVD in diabetes, including hyperglycemia, insulin resistance, and traditional risk factors.
- To emphasize the need for improved risk stratification and screening strategies for CVD in individuals with diabetes.
Summary:
- Diabetes elevates CVD risk due to hyperglycemia, insulin resistance, and other factors, leading to poorer outcomes.
- Obesity's role in atherogenesis, potentially via adipocyte-derived cytokines, is implicated in diabetic CVD.
- Current guidelines recommend risk stratification, but accurately identifying high-risk asymptomatic diabetic patients for further testing remains a challenge.
Impact:
- Optimizing the management of glycemic control and other risk factors in high-risk diabetic populations can reduce cardiovascular mortality.
- Improved screening and prevention strategies are essential to enhance the quality of life for diabetic patients.
- This research underscores the critical link between diabetes and cardiovascular health, necessitating targeted interventions.
Abstract:
Cardiovascular disease, which includes coronary heart disease (CHD), cerebrovascular disease (CVD), and peripheral vascular disease (PVD), is the leading cause of mortality in populations, particularly in the diabetic one. Individuals with diabetes have at least a two-fold to four-fold increased risk of having cardiovascular events and a double risk of death compared with age-matched subjects without diabetes. A decline in mortality from CVD has been shown, but decline due to CHD is consistently lower in individuals with diabetes when compared with non-diabetics. The presence of several factors in diabetes leads to high occurrence of CVD such as hyperglycemia, insulin resistance, and classical and non-classical risk factors (systemic hypertension, dyslipidemia, obesity, proinflammatory condition and others). It is possible that the atherogenic role of obesity may be at least in part due to increased adipocyte production of cytokines. Considering the marked association of diabetes and CVD and unfavorable prognosis following an event, it is important to identify who is at high risk and how to screen. The American Heart Association and American Diabetes Association recommend risk stratification using diagnostic tests. However, the challenge is to accurately identify patients without a prior history of an event and those without symptoms strongly suggesting CVD, in whom additional testing would be indicated in order to achieve the most effective prevention. The benefits of glycemic control and the other risk factors have already been shown and justify optimization of the management of this high-risk population, aiming to reduce cardiovascular mortality disease and improve quality of life.
Related Concept Videos
Coronary Artery Disease I: Introduction
Type II Diabetes I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetic Retinopathy